PriceTargets.com logo

Sandoz Group - SDZNY Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$32.80 As of 04/26/2024 01:00 AM ET
▼ -0.84 (-2.50%)

This chart shows the closing price for SDZNY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sandoz Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SDZNY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SDZNY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Sandoz Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $32.80.

This chart shows the closing price for SDZNY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Sandoz Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/6/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/4/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/5/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/3/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/5/2023Berenberg BankInitiated CoverageBuy
10/5/2023JPMorgan Chase & Co.Initiated CoverageOverweight
10/5/2023Morgan StanleyInitiated CoverageOverweight
(Data available from 4/29/2019 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/2/2023
  • 6 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/1/2023
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/1/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/31/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/30/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/29/2024
  • 1 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/29/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Sandoz Group logo
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Read More

Today's Range

Now: $32.80
Low: $32.48
High: $32.99

50 Day Range

MA: $31.03
Low: $27.81
High: $34.02

52 Week Range

Now: $32.80
Low: $25.71
High: $34.94

Volume

256,082 shs

Average Volume

178,867 shs

Market Capitalization

$14.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Sandoz Group?

The following equities research analysts have issued reports on Sandoz Group in the last twelve months: Berenberg Bank, JPMorgan Chase & Co., and Morgan Stanley.
View the latest analyst ratings for SDZNY.

What is the current price target for Sandoz Group?

0 Wall Street analysts have set twelve-month price targets for Sandoz Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Sandoz Group in the next year.
View the latest price targets for SDZNY.

What is the current consensus analyst rating for Sandoz Group?

Sandoz Group currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SDZNY will outperform the market and that investors should add to their positions of Sandoz Group.
View the latest ratings for SDZNY.

What other companies compete with Sandoz Group?

Other companies that are similar to Sandoz Group include Shionogi & Co., Ltd., Eurofins Scientific, Eisai, Sysmex and Ramsay Health Care. Learn More about companies similar to Sandoz Group.

How do I contact Sandoz Group's investor relations team?

Sandoz Group's physical mailing address is Suurstoffi 14, Rotkreuz 6343, Switzerland, . The company's listed phone number is 41-61-324-11-11 and its investor relations email address is [email protected]. The official website for Sandoz Group is www.sandoz.com. Learn More about contacing Sandoz Group investor relations.